202 related articles for article (PubMed ID: 28679390)
21. Long noncoding RNA LSINCT5 acts as an oncogene via increasing EZH2-induced inhibition of APC expression in osteosarcoma.
Kong D; Li C; Yang Q; Wei B; Wang L; Peng C
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):193-197. PubMed ID: 30420287
[TBL] [Abstract][Full Text] [Related]
22. Effect of long non-coding RNA PVT1 on cell proliferation and migration in melanoma.
Chen L; Ma D; Li Y; Li X; Zhao L; Zhang J; Song Y
Int J Mol Med; 2018 Mar; 41(3):1275-1282. PubMed ID: 29286144
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
24. EZH2-mediated suppression of lncRNA-LET promotes cell apoptosis and inhibits the proliferation of post-burn skin fibroblasts.
Zheng W; Yu A
Int J Mol Med; 2018 Apr; 41(4):1949-1957. PubMed ID: 29393360
[TBL] [Abstract][Full Text] [Related]
25. Integrated bioinformatics analysis of chromatin regulator EZH2 in regulating mRNA and lncRNA expression by ChIP sequencing and RNA sequencing.
Li Y; Luo M; Shi X; Lu Z; Sun S; Huang J; Chen Z; He J
Oncotarget; 2016 Dec; 7(49):81715-81726. PubMed ID: 27835578
[TBL] [Abstract][Full Text] [Related]
26. LncRNA PCAT1 promotes metastasis of endometrial carcinoma through epigenetical downregulation of E-cadherin associated with methyltransferase EZH2.
Zhang C; Shao S; Zhang Y; Wang L; Liu J; Fang F; Li P; Wang B
Life Sci; 2020 Feb; 243():117295. PubMed ID: 31927050
[TBL] [Abstract][Full Text] [Related]
27. LncRNA AWPPH inhibits SMAD4 via EZH2 to regulate bladder cancer progression.
Zhu F; Zhang X; Yu Q; Han G; Diao F; Wu C; Zhang Y
J Cell Biochem; 2018 Jun; 119(6):4496-4505. PubMed ID: 29231261
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA PCAT-1 acts as an oncogene in osteosarcoma by reducing p21 levels.
Huang J; Deng G; Liu T; Chen W; Zhou Y
Biochem Biophys Res Commun; 2018 Jan; 495(4):2622-2629. PubMed ID: 29291409
[TBL] [Abstract][Full Text] [Related]
29. Effects of ANCR lncRNA on the biological behaviors of lung cancer cells A549 and the mechanism.
Ni C; Teng P; Hu P
Transl Cancer Res; 2020 Aug; 9(8):4693-4702. PubMed ID: 35117833
[TBL] [Abstract][Full Text] [Related]
30. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.
Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X
Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584
[TBL] [Abstract][Full Text] [Related]
31. Mislocalized cytoplasmic p27 activates PAK1-mediated metastasis and is a prognostic factor in osteosarcoma.
Chen X; Cates JMM; Du YC; Jain A; Jung SY; Li XN; Hicks JM; Man TK
Mol Oncol; 2020 Apr; 14(4):846-864. PubMed ID: 31872963
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA LINC01133 represses KLF2, P21 and E-cadherin transcription through binding with EZH2, LSD1 in non small cell lung cancer.
Zang C; Nie FQ; Wang Q; Sun M; Li W; He J; Zhang M; Lu KH
Oncotarget; 2016 Mar; 7(10):11696-707. PubMed ID: 26840083
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA ANCR promotes progression of NSCLC by inhibiting E-Ca expression.
Zhou T; Fang JJ; Zhou YX; Li ZP; Jiang L; Han WW; Zhu ZH
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1250-1257. PubMed ID: 32096155
[TBL] [Abstract][Full Text] [Related]
34. Tumor suppressive lncRNA MEG3 binds to EZH2 and enhances CXCL3 methylation in gallbladder cancer.
Li DQ; Ding YR; Che JH; Su Z; Yang WZ; Xu L; Li YJ; Wang HH; Zhou WY
Neoplasma; 2022 May; 69(3):538-549. PubMed ID: 35188401
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer.
Lian Y; Wang J; Feng J; Ding J; Ma Z; Li J; Peng P; De W; Wang K
Tumour Biol; 2016 Nov; 37(11):14929-14937. PubMed ID: 27644252
[TBL] [Abstract][Full Text] [Related]
36. MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10.
Qi Y; Ooi HS; Wu J; Chen J; Zhang X; Tan S; Yu Q; Li YY; Kang Y; Li H; Xiong Z; Zhu T; Liu B; Shao Z; Zhao X
Oncotarget; 2016 Mar; 7(11):12693-703. PubMed ID: 26871474
[TBL] [Abstract][Full Text] [Related]
37. Down-regulated non-coding RNA (lncRNA-ANCR) promotes osteogenic differentiation of periodontal ligament stem cells.
Jia Q; Jiang W; Ni L
Arch Oral Biol; 2015 Feb; 60(2):234-41. PubMed ID: 25463901
[TBL] [Abstract][Full Text] [Related]
38. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
Yang F; Lv LZ; Cai QC; Jiang Y
World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
[TBL] [Abstract][Full Text] [Related]
39. Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer.
Chen WM; Huang MD; Sun DP; Kong R; Xu TP; Xia R; Zhang EB; Shu YQ
Oncotarget; 2016 Mar; 7(9):9773-87. PubMed ID: 26799422
[TBL] [Abstract][Full Text] [Related]
40. The role of long non-coding RNA HOTAIR in the progression and development of laryngeal squamous cell carcinoma interacting with EZH2.
Zheng J; Xiao X; Wu C; Huang J; Zhang Y; Xie M; Zhang M; Zhou L
Acta Otolaryngol; 2017 Jan; 137(1):90-98. PubMed ID: 27542077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
